Renal hemangioendothelioma: a case report
DOI:
https://doi.org/10.47464/MetroCiencia/vol30/1/2022/120-127Keywords:
Renal hemangioendothelioma, nephrectomy, immunohistochemistryAbstract
Hemangioendothelioma is reported as a rare vascular neoplasm, with usual locations such as liver, skin and less frequently in the spleen, kidney and lung. Renal hemangioendothelioma is an extremely rare tumor. It mainly affects middle-aged people regardless of gender, among the symptoms that are usually present are pain in the lumbar region and hematuria. The diagnosis is established by histopathology. Radical nephrectomy and radiotherapy are indicated as surgical treatment of choice; to date, no effective systemic chemotherapy has been described for metastatic disease. At present, diagnostic and therapeutic experience are limited in our environment. We report the case of renal hemangioendothelioma of a 69-year-old male patient, an exhaustive literature search was carried out, few reported cases of this pathology were identified. We report a case of renal HE in a 69-year-old man who presented mainly with abdominal pain. Urotomography revealed a left renal mass of 11.3 X 9.5 X 8.0 CM with a volume of 449.15 CC. Radical nephrectomy plus para-aortic and intercavo-aortic lymphadenectomy was performed. The diagnosis was made based on histological and immunohistochemical findings, postoperative follow-up was performed at 3 months, no recurrence was found in the surgical bed. The expected results with this descriptive study of a case are intended to contribute to the casuistry of our country as well as being a worldwide reference in terms of the report of renal hemangioendothelioma and its clinical and surgical management.
Downloads
References
Roy S, Parwani A V. Primary Renal Epithelioid Hemangioendothelioma. Case Rep Pathol. 2012;2012(Figure 3):1–3.
Chatterjee D PA. Renal Hemangioendothelioma. Int surg. 1982;67 (4):373–5.
Peters HJ, Nuri M, Muenzenmaier R. Hemangioendothelioma of the kidney: a case report and review of the literature. J Urol. 1974;112(6):723–6.
Karasavvidou F, Barbanis S, Gravas S, Ioannou M, Oeconomou A, Pappa D, et al. Primary renal epithelioid hemangioendothelioma. Onkologie. 2009;32(4):203–5.
Xiao Y, Wang C, Song Y, Wang C, Wang X, Zhang X, et al. Primary epithelioid hemangioendothelioma of the kidney: The first case report in a child and literature review. Urology [Internet]. 2013;82(4):925–7. Available from: http://dx.doi.org/10.1016/j.urology.2013.04.006
Tolkach Y, Petrov S, Lerut E, Van Poppel H. Epithelioid hemangioendothelioma of the kidney treated with sunitinib. Onkologie. 2012;35(6):376–8.
Antonescu C. Malignant vascular tumors-an update. Mod Pathol. 2014;27(SUPPL. 1):30–8.
Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: A proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32(6):924–7.
Liu Y, Liu A, Wu J, Liu T. Epithelioid hemangioendothelioma arising from the kidney: A rare case report. Medicine (Baltimore). 2019;98(34):e16537.
Zhang J, Wu B, Zhou GQ, Zhang RS, Wei X, Yu B, et al. Composite hemangioendothelioma arising from the kidney: Case report with review of the literature. Int J Clin Exp Pathol. 2013;6(9):1935–41.
B. Ljungberg (Chair), L. Albiges, K. Bensalah, A. Bex (Vice-chair), R.H. Giles (Patient Advocate) MH, M.A. Kuczyk, T. Lam, L. Marconi, A.S. Merseburger, T. Powles, M. Staehler AV, Guidelines Associates: Y. Abu-Ghanem, S. Dabestani, S. Fernández-Pello Montes, F. Hofmann, T. Kuusk RT. EAU Guidelines on Renal Cell Carcinoma. Eur Urol Suppl. 2019;71.
Molina Palma MI, Cervantes Góngora JA, García De La Torre E, Conde Pérez De La Blanca I, Ramírez Tortosa CL. Hemangioendotelioma Epitelioide primario intraoral. Presentación de un caso y revisión de la literatura. Acta Otorrinolaringol Esp. 2002;53(3):215–8.
Ortega L. Tumores epitelioides Epitelioide [Internet]. Patología molecular, imagen digital y gestión. 2013. Available from: https://www.seap.es/documents/228448/531231/04_Ortega.pdf
Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol. 2013;30(1):29–44.
Huang D, Ding Y, Li Y, Luo WM, Zhang ZF, Snider J, et al. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Cancer Res. 2010;70(3):1053–62.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Mayra Molina Herrera, Edison Llamuca Naranjo, Janeth Salazar Arias, Duval Borja Menéndez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
